opposite story for michael kors, that stock down for the second day in a row as stern ag and barkleys reduced their price targets for the high-end retailer. both firms siting increased promotional activity that could put pressure on margins. shares tumbled to $79.44. >>> john and johnson reported earnings topped by sells of the hepatitis c treatment. the company cautioned the pill will lose some steam later this year as newer rivals come to the markets. still, shares were about 2% lower today. they finished at $103.28. >>> you may not know about mash, it's a liver disease that affects many americans. with no medication on the market, it's being referred to as the new help tpatitis c beca treatment is expected to approach $40 billion. more on the dash to treat gnash. >> reporter: you probably never heard of it but some say it could become the next global epidemic, nash is a progressive liver disease often associated with obesity. drug makers are eyeing a huge and still growing potential market. >> the is probably 6 million, 6.5 million people with scarring or harding of the liver conse

william blare and stern ag ex pressed concerns about kors this week. beyond saturation, analysts point to inkreecreased promotiod margins as other worries. not everyone is bearish on kors. it's maintaining a buy rating and erin murphy is reit raising her over wait. >> this is a global story misunderstood by the street. it's growing across multiple categories, over the next two to three years, the near term or that intermediate term upside comes from the european market, what they are doing there. it's extremely transformational. >> reporter: while many compare michael kors to coach which suffered from market share and stock price declines, murphy thinks ralph lauren is a better competitive to kors since both have large product lines. the sales growth has been seller, a performance level only sustainable for so long. however, piper's survey still indicates kors is a top desired handbag brand potentially giving the brand some back to school sales strength. for "nightly business report", i'm courtney regan. >>> our market monitor guest tonight says there

chuck grom, managing director with stern ag.t the outcome, turns out adidas claimed victory, arian gene tee that beat the netherlands who is spot sored by nike meaning arian gene tee that and germany in the final. the germany sponsor, of course, that would be adidas. that's sales lift for the apparel winning country. adidas winning big. we talked to both ceos with the world cup, and they both, carl, were banking -- spending so much money, no figures, but they spend a lot, seeing boost, and they both said they are sustained boosts. adidas is the official sponsor, ensured to have the winning team, that is a big win. nike, interestingly enough sponsored more teams, ten teams r for the first time. interesting business battle to watch in the world cup. >> back to the most recent nike quarter in the marketing costs, expensive to market these things and promote, but, obviously, you get it back with the global audience. >> i say there's a bright spot for nike in terms of their win, it's been popular to watch the world cup in the u.s., a

age. currently lack effective diagnostic tools or treatments for either disease. so, the question i would like to ask for dr. sternnd dr. vanlandingham, how can you use what you learn about traumatic brain injury to inform study about other age-related neurodegenerative diseases. dr. stern? senator warren, thank you for that question. that was the question that got me involved in the study of chronic traumatic encephalopathy. as an alzheimer researcher -- alzheimer's researcher, i was never very interested, except i once was at a lecture and mr. roommate was in the audience, and it led me to find out about this burgeoning topic of chronic traumatic encephalopathy. and the reason i got involved was for just that reason. it was a close enough cousin to alzheimer's and other diseases that have been studied that we could exploit what we find out about one to learn about the other. and so with chronic traumatic encephalopathy, we know the necessary variable for developing this disease. the necessary variable is repetitive brain trauma. articulately said, that is not the only variable. who hasnow everyone this disease h

participation rate has been in the age range of 25 to 45, individuals with a significant number of potential income earning years left. >> lindsey piegza, chief economist of sterne agee, always good to have you on the broadcast. >> thank you so much for having me. >> bloomberg is "on the markets." julie hyman joins me now. how are the markets doing? >> they have pretty much stabilized after the minutes. the read, as mike mckee talked about, is that we are still sort of data-dependent and waiting to see what happens next. the s&p and dow are remaining steady -- actually, they have gained a little bit versus earlier. if you look at what individual stocks we are watching, american airlines is on the list. those shares are on the rise and are pulling up stocks of other u.s. airlines also. the second-quarter pretax margins exceed forecasts. the companies producing a 6% rise in revenue each seat flown per mile. that is the benchmark gauge for the industry. we will have more in 30 minutes and talk a little bit more about the fed reaction and the outlook for the earnings season. ♪ >> welcome back to the second half-hour of "bottom line" on bloomberg television. i am are

ages ago. them -- i ampo for a full fan, full disclosure. good morning. with me, olivia sterns and adam johnson. get us going on tech m&a. >> business is booming. we saw that with family dollar and dollar tree. nearly twice the level of last year. one of the players is google. they have tripled in the first half of the year to $4.2 billion. our guest is stephen leavy. he is here to help us figure it out. also, michael, the chairman and ceo of asset management. you are the expert on google here. you did an interview with who you say will be the next ceo. they have all these acquisitions. they're getting into so many different areas. they're getting into driverless cars, drones. what is the glue that is holding all these businesses together? >> it is the google in the cloud. the smart google that exists that we can access on any device seamlessly. one of the things that i introduced was the tools were doing something on your phone -- then you move to your computer. you still carry it on seamlessly there. -- much of about that money was to buy next. things,the internet of smart ho

age of british is nearing? >> you can follow me on twitter. ♪ . . >> welcome back to "the pulse" live from bloomberg's european headquarters in london. i am olivia sternse ecb is expected to keep interest rates unchanged today. this after the central bank cut its benchmark rates to a record low last month and introduced a negative deposit rate. the decision will be announced today at 12:45 london time. we will bring you maggie -- bring you maggio draghi's news conference. we sat down for an exclusive interview in frankfurt. >> the ecb has been so determined. [indiscernible] germany is voting on whether to introduce a nationwide minimum wage today. the pay will be set at eight euros $.50 per hour. it was introduced by angela merkel's third term coalition. critics say it risks killing jobs. the u.k. has what some might say is a long and glorious past when it comes to engineering. firmware ways to radar, britain has pioneered some of the most important technologies in the world. a celebration of british engineering took late and three finalists all look likely to fly the flag for many years to come era get --. >> a supersonic jet, a super sensor, and a su

stern. >> over to you, brian. ever the class act, eastbound though he accepted the challenge, matt is donating money to charity, a very cool move. now the challenge is on. avo: waves don't care what age. take them on the way you always have. live healthy and take one a day men's 50+. a complete multivitamin with 7 antioxidants to support cell health. age? who cares. a body at rest tends to stay at rest... while a body in motion tends to stay in motion. staying active can actually ease arthritis symptoms. but if you have arthritis, staying active can be difficult. prescription celebrex can help relieve arthritis pain so your body can stay in motion. because just one 200mg celebrex a day can provide 24 hour relief for many with arthritis pain and inflammation. plus, in clinical studies, celebrex is proven to improve daily physical function so moving is easier. celebrex can be taken with or without food. and it's not a narcotic. you and your doctor should balance the benefits with the risks. all prescription nsaids, like celebrex, ibuprofen, naproxen and meloxicam have the same cardiovascular warning. they all may increase the chance of heart attack or stroke, which can lead to death. t